Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With REMI.
The goal of this clinical trial is to test Epitel's™ Remote EEG Monitoring System's (REMI™) ability to record electroencephalography (EEG) of seizure events in an ambulatory setting for extended periods (14 - 28 days) in patients presenting with questionable seizure characterization. The main questions it aims to answer are: • Can more seizure events be recorded in fourteen (14) days than can be recorded in three (3) days? • Do treating clinicians find clinical value in extended fourteen (14) - twenty-eight (28) days of EEG? Participants will wear a portable EEG device (REMI) for fourteen (14) to twenty-eight (28) days in their home/community setting.
• Patients have a reported history of seizures (epileptic, non-epileptic, or unknown),
• Have a minimum reported seizure rate of one every two weeks,
• Are prescribed an ambulatory EEG study as part of routine care,
• Is Male or Female between the ages of 18 and 70,
• Can understand and sign written informed consent, or have a legal guardian provide consent,
• The Patient (or Primary Caregiver) must be competent to follow all study procedures,
• The Patient must be willing to use the System for a prolonged period (up to 30 days), for a minimum of 20 hours/day.